Miravant Medical Technologies Inc.
MRVT · OTC
12/31/2004 | 12/31/2003 | 12/31/2002 | 12/31/2001 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $5 |
| % Growth | – | -100% | -89.3% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $1 |
| Gross Profit | $0 | $0 | $0 | $4 |
| % Margin | – | – | 4% | 80.1% |
| R&D Expenses | $8 | $8 | $10 | $13 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $5 | $5 | $6 | $6 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $13 | $12 | $15 | $19 |
| Operating Income | $13 | $12 | $15 | $16 |
| % Margin | – | – | 3,057.1% | 334.1% |
| Other Income/Exp. Net | -$3 | $10 | -$15 | -$16 |
| Pre-Tax Income | $13 | $23 | $15 | $16 |
| Tax Expense | $3 | -$5 | $1 | $1 |
| Net Income | -$16 | -$7 | -$16 | -$16 |
| % Margin | – | – | -3,198.4% | -350.2% |
| EPS | -0.48 | -0.3 | -0.78 | -0.88 |
| % Growth | -60% | 61.5% | 11.4% | – |
| EPS Diluted | -0.48 | -0.3 | -0.78 | -0.88 |
| Weighted Avg Shares Out | 33 | 25 | 21 | 19 |
| Weighted Avg Shares Out Dil | 33 | 25 | 21 | 19 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $1 | $2 | $2 |
| EBITDA | -$13 | -$22 | -$14 | -$14 |
| % Margin | – | – | -2,716% | -296.6% |